Tumour markers

GJS Rustin, MEL Van der Burg, JS Berek - Annals of Oncology, 1993 - Elsevier
Background There is a need to discover new tumour markers for ovarian carcinoma as well
to delineate how the best currently available marker, CA 125 should be used. Materials and …

The prognostic value of serum CA 125 in patients with advanced ovarian carcinoma: an analysis of 573 patients by the Medical Research Council Working Party on …

PM Fayers, G Rustin, R Wood, A Nelstrop… - International Journal of …, 1993 - ijgc.bmj.com
A number of studies have suggested that serum CA 125 levels may be an important
prognostic factor for survival of patients with ovarian carcinoma. We investigated, in a large …

Distribution of CA 125 in embryonic tissues and adult derivatives of the fetal periderm

H Hardardottir, TH Parmley II, JG Quirk Jr… - American journal of …, 1990 - Elsevier
New murine monoclonal antibodies to a partially purified CA 125 antigen were developed
and identified as M 2 and M 11. With immunohistochemical techniques, these new …

Early serum CA125 response and outcome in epithelial ovarian cancer

CWE Redman, GR Blackledge, K Kelly, J Powell… - European Journal of …, 1990 - Elsevier
The prognostic value of serum CA125 levels before and after two courses of chemotherapy
was assessed in 50 patients with advanced epithelial ovarian cancer. Patients with serum …

Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3′ deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging

SD Richard, B Bencherif, RP Edwards… - Nuclear medicine and …, 2011 - Elsevier
INTRODUCTION: Positron emission tomography (PET)/computed tomography (CT) imaging
of suspected new and recurrent ovarian carcinoma was performed to assess the relationship …

CA 125 regression: a model for epithelial ovarian cancer response

RE Buller, ML Berman, JD Bloss, A Manetta… - American journal of …, 1991 - Elsevier
The rate of decline of CA 125 in effectively treated epithelial ovarian cancer is described by
the exponential regression curve CA 125= EXP [is (days after surgery)]. In this equation i, the …

[PDF][PDF] Monitoring ovarian cancer patients during chemotherapy and follow-up with the serum tumor marker CA125

SOA Hassaan - Dan Med J, 2018 - content.ugeskriftet.dk
Worldwide, ovarian cancer is the leading cause of death from gynecological cancers [1, 2].
In Denmark, epithelial ovarian/fallopian tube or primary serous peritoneal cancer is the …

The prognostic value of early CA125 serum assay in epithelial ovarian carcinoma

J Fisken, RC Leonard, M Stewart, GJ Beattie… - British journal of …, 1993 - nature.com
We examined the prognostic value of early serum CA125 assay in 58 patients with
advanced epithelial ovarian cancer together with residual disease, age, tumour grade …

Transformation of NIH3T3 mouse fibroblast cells by MUC16 mucin (CA125) is driven by its cytoplasmic tail

P Giannakouros, I Matte… - … journal of oncology, 2015 - spandidos-publications.com
Abstract MUC16 (CA125) is a transmembrane mucin that contributes to the progression of
epithelial ovarian cancer (EOC). Expression of MUC16 is not detectable in the epithelial …

Pre‐operative discrimination between benign and malignant ovarian tumors using a combination of CA125 and CA15. 3 serum assays

C Yedema, L Massuger, J Hilgers… - … Journal of Cancer, 1988 - Wiley Online Library
Serum levels of CA125 and CA15. 3 were measured in 70 patients presenting with an
ovarian neoplasm, of whom 38 had an ovarian malignancy and 32 a benign ovarian tumor …